Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CLEVELAND, July 03, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that…
eureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges
The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3…
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
YUSIMRY™ (adalimumab-aqvh) product image YUSIMRY™ (adalimumab-aqvh) – list price $995 per carton of two 40…
Zymeworks Announces Participation in Upcoming Investor Conference
VANCOUVER, British Columbia, July 03, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution
— Ready-to-dilute, multi-dose vials reduce compounding time and waste — BRIDGEWATER, N.J., July 03, 2023…
Journey Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of July 10, 2023
SCOTTSDALE, Ariz., July 03, 2023 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”),…
NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva
MATFORS, Sweden, July 03, 2023 (GLOBE NEWSWIRE) — NorthX Biologics (‘NorthX’), a leading Nordic development…
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
Company completes spin-off from Labcorp and begins trading on Nasdaq under ticker “FTRE” Independent company…
SoLVBL Solutions Inc. Shares Resume Trading and Provides Update on Its Business Lines
Toronto, Ontario–(Newsfile Corp. – July 3, 2023) – SoLVBL Solutions Inc. (CSE: SOLV) (OTCQB: SOLBF)…
Monza beckons for TOYOTA GAZOO Racing
Toyota City, Japan, Jul 3, 2023 – (JCN Newswire) – TOYOTA GAZOO Racing targets a…
Unveiling the Future of Enterprise AI Solutions: World AI Show Returns for its 42nd Edition in Singapore
Trescon is set to organize the 42nd edition of World AI Show, a global platform…
DigitalOcean Announces Date of Second Quarter 2023 Earnings Conference Call
NEW YORK–(BUSINESS WIRE)–DigitalOcean Holdings, Inc. (NYSE: DOCN), the cloud for startups and small-to-medium-sized businesses (SMBs),…
Cyble Revolutionizes Cybersecurity Collaboration with launch of its Global Partner Program “Cyble Partner Network”
ATLANTA–(BUSINESS WIRE)–#AI–Cyble, the leading AI-powered global cyber threat intelligence provider, is excited to announce the…
CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committee
BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation…
Byline Bancorp, Inc. Completes the Merger with Inland Bancorp, Inc.
CHICAGO–(BUSINESS WIRE)–Byline Bancorp, Inc. (“Byline”) (NYSE: BY), the parent company of Byline Bank, announced today…
Startup Invest Inc. Introduces Revolutionary Machine-Learning Investment Platform
Plus a $200K Trading Tournament and Exclusive Investment Opportunity LOS ANGELES–(BUSINESS WIRE)–#DataDrivenInvesting–Invest Inc., a Wyoming-based…
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1…
22nd Century Announces 1-for-15 Reverse Stock Split
Re-Affirms Full-Year Outlook of $105 Million to $110 Million in Net Sales BUFFALO, N.Y., July…
Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
Alan Fisher appointed Chair of the Board of Directors Tim Cunningham joins as Chief Financial…
Kissei introduces Iktos AI Drug Discovery System
Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 – Iktos, a…